Dow Signs HPPO Joint Venture Agreement with BASF
The Dow Chemical Company announced that it has signed a joint venture agreement with BASF to construct a new propylene oxide manufacturing facility using the recently co-developed hydrogen peroxide route to propylene oxide (HPPO) technology. Construction of the new 300,000 MT plant will begin this year with startup planned in early 2008. Financial terms of the transaction were not disclosed.
The joint venture will build and operate the commercial-scale HPPO plant in Antwerp Belgium. A separate joint venture company will own and further develop the HPPO (hydrogen peroxide route to propylene oxide) technology. The two companies will have equal off-take rights to the PO produced by the Antwerp plant.
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/ceurope/images/newsletter.png)
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.